510(k) · Cleared
ClearedHBA1C Linearity Set
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cone Bioproducts · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)
Cleared on Oct 4, 2005 as substantially equivalent to K040535 (Cliniqa Corporation, 2004) after a 71-day review. Its family tree reaches back 1 generation to 2004. 2 later devices descend from it.
- Decided
- Oct 4, 2005
- Review
- 71 days
- Class
- Class I
- Product code
- JJX
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K040535 (2004). 2 later devices descend from it, 1 citing it directly.
- Root · 1 generation backK040535 Linical Enzyme Calibration Verifiers Levels a-E for Beckman Coulter…Cliniqa Corporation · 2004
- This deviceK052010 HBA1C Linearity SetCone Bioproducts · 2005
- Descendant · cites it directly · 1 of its ownK121534 Cone-Trol Hemoglobin A1C Control SetCone Bioproducts · 2012
- Descendant · 2 generations on · 0 of its ownK162514 Multichem A1cTechnopath Manufacturing · 2016
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K040535 | Linical Enzyme Calibration Verifiers Levels a-E for Beckman Coulter Synchron… | Cliniqa Corporation | 2004 | — |
| 0 (this device) | K052010 | HBA1C Linearity Set | Cone Bioproducts | 2005 | — |
| +1 | K121534 | Cone-Trol Hemoglobin A1C Control Set | Cone Bioproducts | 2012 | — |
| +2 | K162514 | Multichem A1c | Technopath Manufacturing | 2016 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2012 | 1 | 0 |
| 2016 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K040535 | Linical Enzyme Calibration Verifiers Levels a-E for Beckman Coulter Synchron SystemsSummary page 1…JJX Regulatory Class: Class I Predicate Devices: The HbAlc Linearity Set is substantially equivalent to LiniCAL Enzyme Calibration Verifiers (k04053 5) for its stated intended use. Device Description: The HbAlc Linearity Set is prepared from human blood to which stabilizers are… | 2004 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K121534 | Cone-Trol Hemoglobin A1C Control Set | 2012 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- Of its descendants, K121534 (Cone Bioproducts, 2012) has gone furthest, with 1 descendant of its own.
How does its category compare?
All JJX devicesJJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JJX
2in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · JJX
31in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JJX
1in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JJX
22in 2025
MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 53 | 3 | 2 |
| 2008 | 8 | 52 | 3 | 0 |
| 2009 | 17 | 80 | 0 | 1 |
| 2010 | 24 | 80 | 3 | 6 |
| 2011 | 19 | 62 | 2 | 62 |
| 2012 | 15 | 40 | 0 | 32 |
| 2013 | 19 | 37 | 0 | 51 |
| 2014 | 22 | 30 | 1 | 48 |
| 2015 | 11 | 65 | 1 | 67 |
| 2016 | 6 | 31 | 2 | 37 |
| 2017 | 2 | — | 0 | 19 |
| 2018 | 0 | — | 2 | 35 |
| 2019 | 0 | — | 0 | 82 |
| 2020 | 0 | — | 0 | 77 |
| 2021 | 0 | — | 1 | 43 |
| 2022 | 0 | — | 0 | 24 |
| 2023 | 0 | — | 0 | 22 |
| 2024 | 0 | — | 0 | 30 |
| 2025 | 0 | — | 0 | 22 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Hemoglobin Al c Linearity is intended for use as quality control material to demonstrate linearity throughout the reportable range of Hemoglobin AIc (IobAl c%) for Immunoassay and HPLC test methods using protocols established in individual laboratories.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K052010 · printed Nov 3, 2026
Cite this page
510(k) Report. “K052010: HBA1C Linearity Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K052010
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026